SEC Form 4 · accession 0001209191-15-002133
bluebird bio, Inc. · BLUE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Eric Sullivan
Officer — Principal Accounting Officer
Period of report
Jan 2, 2015
Accepted (ET)
Jan 6, 2015 · 4:05 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001293971
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 2, 2015 | M | 3,500 | $20.70 | A | 3,500 | D | |
| Common Stock | Jan 2, 2015 | M | 250 | $24.47 | A | 3,750 | D | |
| Common StockF2 | Jan 2, 2015 | S | 1,169 | $88.2356 | D | 2,581 | D | |
| Common StockF3 | Jan 2, 2015 | S | 446 | $88.8936 | D | 2,135 | D | |
| Common StockF4 | Jan 2, 2015 | S | 862 | $90.174 | D | 1,273 | D | |
| Common StockF5 | Jan 2, 2015 | S | 245 | $91.1632 | D | 1,028 | D | |
| Common StockF6 | Jan 2, 2015 | S | 943 | $92.0156 | D | 85 | D | |
| Common StockF7 | Jan 2, 2015 | S | 85 | $92.9569 | D | 0 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (right to buy)F8 | $20.70 | Jan 2, 2015 | M | 3,500 | D | — | Dec 2, 2023 | Common Stock | 3,500 | 8,500 | D |
| Stock Option (right to buy)F9 | $24.47 | Jan 2, 2015 | M | 250 | D | — | Mar 3, 2024 | Common Stock | 250 | 7,750 | D |
Explanation of responses
- F1The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 17, 2014.
- F2The range in prices for the transaction reported on this line was $87.53 to $88.52. The average weighted price was $88.2356. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F3The range in prices for the transaction reported on this line was $88.54 to $89.51. The average weighted price was $88.8936. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F4The range in prices for the transaction reported on this line was $89.62 to $90.62. The average weighted price was $90.1740. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F5The range in prices for the transaction reported on this line was $90.63 to $91.61. The average weighted price was $91.1632. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F6The range in prices for the transaction reported on this line was $91.66 to $92.50. The average weighted price was $92.0156. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F7The range in prices for the transaction reported on this line was $92.92 to $92.99. The average weighted price was $92.9569. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F8This option vests over a four-year period, at a rate of twenty-five percent(25%) on November 11, 2014 and in 36 equal monthly installments thereafter.
- F9This option vests over a four-year period, at a rate of twenty-five percent(25%) on January 1, 2015 and in 36 equal monthly installments thereafter.